NCT00100399View on ClinicalTrials.gov

Fluarix Immunogenicity and Safety Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,050

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix

Trial Locations (4)

14642

University of Rochester, Rochester

21201

University of Maryland Baltimore, Baltimore

77030

Baylor College of Medicine, Houston

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00100399 - Fluarix Immunogenicity and Safety Trial | Biotech Hunter | Biotech Hunter